SARMS Complete Ingredients & Drug Interactions
by AAS Applied Anabolic Science
What is this page for?
First and foremost: checking SARMS Complete against your medications. The heart of this page is the interaction checker and the full interaction report — how this product’s ingredients may interact with prescription and over-the-counter medicines you may be taking.
Around that, we add a pharmacist’s high-level view of the product as a whole — what’s inside, the evidence for its stated use, how transparent the label is, and what safety data exists — so you can see the full picture in one place. It’s educational information from our licensed clinical databases and the clinical staff at HelloPharmacist — not medical advice — and we don’t sell or endorse products. Our editorial policy
SARMS Complete is a dietary supplement by AAS Applied Anabolic Science with 4 active ingredients. Its ingredients are commonly taken for muscle building, strength gains, fat loss / body recomposition.Based on those ingredients, 612 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are ((2S)-3-(4-Cyanophenoxy)-N-[4-Cyano-3-(Trifluorometh-yl)phenyl]-2-Hydroxy-2-Methylpropanamide, 4-((R)-2-((R)-2,2,2-Trifluoro-1-Hydroxyethyl)Pyrrolidin-1-Yl)-2-TrifluoroMethyl)Benzonitrile, (2S)-3-(4-Acetamido-Phenoxy)-2-Hydroxy-2-Methyl-N-(4-Nitro-3-Trifluoromethyl-Phenyl)-Propionamide. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.
Check Your Meds Against SARMS Complete by AAS Applied Anabolic Science
Ask about any prescription or over-the-counter medication and we check it for interactions with SARMS Complete by AAS Applied Anabolic Science — and tell you which ingredient is responsible.
AI summaries are generated from our interaction database for education only — always confirm with your pharmacist. How we use AI
Ask the Pharmacist
A licensed pharmacist will answer your question by email — free, usually within 24 hours.
Got it — thank you!
A licensed pharmacist will answer within 24 hours. Keep an eye on your email (worth checking spam, just in case).
HelloPharmacist Scorecard of SARMS Complete by AAS Applied Anabolic Science
Four independent checks of what is known — a summary of the available information, not a grade of the product itself.
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
The stated purpose hasn't been mapped to our evidence data yet.
Why this rating?
- We haven't mapped this product's purpose to our evidence data yet — it'll be graded on the next content refresh.
Most active ingredients don't disclose an individual amount — you can't tell how much of each you're getting.
Why this rating?
- The label discloses an exact amount for 0 of its 4 active ingredients.
- “SARMS Complete Blend” is a proprietary blend — the label gives one combined amount (89 mg) without saying how much of each component you get.
The most serious documented interaction for these ingredients is Moderate. Check your medications for a personalized result.
Why this rating?
- 3 of the 3 matched ingredients can interact with medications — Ostarine, Andarine, Ligandrol.
- The most serious interaction on file is rated Moderate.
- For scale: 613 individual medications appear in the full list. A big number alone doesn't make a product dangerous — what matters is whether YOUR medication is on it, so run yours through the interaction checker on this page.
Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.
Why this rating?
- We hold adverse-effect (side-effect) data for 3 of the 3 matched ingredients.
- Pregnancy & breastfeeding safety ratings cover 3 of 3.
- General safety write-ups exist for 3 of 3.
- Remember: this measures how much safety information exists. Thin data is not the same as being safe.
HelloPharmacist summaryFormula with limited ingredient disclosure with no assessable stated purpose. Moderate medication interactions have been identified, and safety information is well characterized.
Assessment coverage: 3 of 4 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Jan 7, 2019.
This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed
General information
Key facts about SARMS Complete, straight from the product label.
| Brand | AAS Applied Anabolic Science |
|---|---|
| Net contents | 60 Capsule(s) |
| Market status | Off market |
| Date entered into DSLD | Jan 7, 2019 |
| DSLD ID | 181751 |
| Product type | Non-nutrient/non-botanical |
| Supplement form | Capsule |
| Dietary claims / uses | No Claim |
| Intended target group(s) | Adult (18 - 50 Years) |
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.
Supplement Facts
The label details for SARMS Complete by AAS Applied Anabolic Science, sourced from the NIH Dietary Supplement Label Database.
Supplement Facts
Other ingredients: Maltodextrin, Gelatin, Blue 1, Red 1
Tap any ingredient to jump to its full detail below.
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
General Statements
Industry leading potency Zero side effects
FDA Statement of Identity
Dietary Supplement
Is this label outdated? Report a formula or label change and our pharmacy team will review it.
SARMS Complete by AAS Applied Anabolic Science label
The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.
Label images are published by the NIH Dietary Supplement Label Database for the version of this product on file. Always read your actual product label.
View the full label (PDF)The Ingredients in SARMS Complete by AAS Applied Anabolic Science
These are the 4 active ingredients this product is made of. Select any to open its full monograph.
Serving size1 Capsule(s) Dosage formCapsule Servings per container60 Amounts shown are per serving.
Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.
SARMS Complete Blend
- › 3beta-Hydroxyetioallocholan-5-ene-17-one
- › (2S)-3-(4-Acetamido-Phenoxy)-2-Hydroxy-2-Methyl-N-(4-Nitro-3-Trifluoromethyl-Phenyl)-Propionamide
- › ((2S)-3-(4-Cyanophenoxy)-N-[4-Cyano-3-(Trifluorometh-yl)phenyl]-2-Hydroxy-2-Methylpropanamide
- › 4-((R)-2-((R)-2,2,2-Trifluoro-1-Hydroxyethyl)Pyrrolidin-1-Yl)-2-TrifluoroMethyl)Benzonitrile
Other (inactive) ingredients: Maltodextrin, Gelatin, Blue 1, Red 1. These complete the product’s ingredient list but are not active constituents.
SARMS Complete by AAS Applied Anabolic Science Drug Interactions
SARMS Complete contains 4 ingredients, and 3 of them have known drug interactions. Altogether they interact with 612 medications. Here’s the picture, then you can look up your own drug.
Want to check YOUR meds against SARMS Complete?
Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.
Go to the checkerIngredients driving the most interactions
Individual Drug Interactions
The ingredients in SARMS Complete interact with 612 drugs. Click any drug to see the details.
3 of the 4 ingredients in SARMS Complete interact with drugs. Each result below shows which ingredient is responsible. ((2S)-3-(4-Cyanophenoxy)-N-[4-Cyano-3-(Trifluorometh-yl)phenyl]-2-Hydroxy-2-Methylpropanamide 4-((R)-2-((R)-2,2,2-Trifluoro-1-Hydroxyethyl)Pyrrolidin-1-Yl)-2-TrifluoroMethyl)Benzonitrile (2S)-3-(4-Acetamido-Phenoxy)-2-Hydroxy-2-Methyl-N-(4-Nitro-3-Trifluoromethyl-Phenyl)-Propionamide
LevofloxacinLeva-pak, Levaquin, Levaquin Injection
How Levofloxacin interacts with SARMS Complete — through 2 ingredients. Tap an ingredient for the detail:
4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Levofloxacin interaction((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Levofloxacin interactionLevonorgestrelKyleena, Levonelle 1500, Levonelle One Step, Liletta, Mirena, Norgeston +2 more
How Levonorgestrel interacts with SARMS Complete — through 2 ingredients. Tap an ingredient for the detail:
((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Levonorgestrel interaction4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Levonorgestrel interactionLevonorgestrel, Ethinyl EstradiolLogynon ED, Microgynon 30, Nordette, Ovranette, Quartette, Trinordiol +1 more
How Levonorgestrel, Ethinyl Estradiol interacts with SARMS Complete — through 2 ingredients. Tap an ingredient for the detail:
4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Levonorgestrel, Ethinyl Estradiol interaction((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs, Cytochrome P450 3a4 (cyp3a4) Inhibitors Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Levonorgestrel, Ethinyl Estradiol interactionLomefloxacinMaxaquin
How Lomefloxacin interacts with SARMS Complete — through 2 ingredients. Tap an ingredient for the detail:
4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Lomefloxacin interaction((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Lomefloxacin interactionLomitapideJuxtapid
How Lomitapide interacts with SARMS Complete — through 2 ingredients. Tap an ingredient for the detail:
4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Lomitapide interaction((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Lomitapide interactionLonapegsomatropin-tcgdSkytrofa
How Lonapegsomatropin-tcgd interacts with SARMS Complete — through 1 ingredient. Tap an ingredient for the detail:
((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideCytochrome P450 3a4 (cyp3a4) Inducers Moderate
Interaction Summary
Theoretically, concomitant use of ostarine with CYP3A4 inducers could decrease the clinical effects of ostarine.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Lonapegsomatropin-tcgd interactionLopinavir, RitonavirKaletra
How Lopinavir, Ritonavir interacts with SARMS Complete — through 2 ingredients. Tap an ingredient for the detail:
((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs, Cytochrome P450 3a4 (cyp3a4) Inhibitors Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Lopinavir, Ritonavir interaction4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Lopinavir, Ritonavir interactionLorlatinibLorbrena
How Lorlatinib interacts with SARMS Complete — through 1 ingredient. Tap an ingredient for the detail:
((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideCytochrome P450 3a4 (cyp3a4) Inducers Moderate
Interaction Summary
Theoretically, concomitant use of ostarine with CYP3A4 inducers could decrease the clinical effects of ostarine.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Lorlatinib interactionLovastatinAltocor, Mevacor
How Lovastatin interacts with SARMS Complete — through 2 ingredients. Tap an ingredient for the detail:
4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Lovastatin interaction((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Lovastatin interactionLuliconazoleLuzu
How Luliconazole interacts with SARMS Complete — through 1 ingredient. Tap an ingredient for the detail:
((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideCytochrome P450 3a4 (cyp3a4) Inducers Moderate
Interaction Summary
Theoretically, concomitant use of ostarine with CYP3A4 inducers could decrease the clinical effects of ostarine.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Luliconazole interactionLumiracoxibPrexige
How Lumiracoxib interacts with SARMS Complete — through 2 ingredients. Tap an ingredient for the detail:
((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs, Cytochrome P450 2c9 (cyp2c9) Substrates Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Lumiracoxib interaction4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Lumiracoxib interactionLurbinectedinZepzelca
How Lurbinectedin interacts with SARMS Complete — through 2 ingredients. Tap an ingredient for the detail:
4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Lurbinectedin interaction((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Lurbinectedin interactionMacitentanOpsumit
How Macitentan interacts with SARMS Complete — through 2 ingredients. Tap an ingredient for the detail:
((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Macitentan interaction4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Macitentan interactionMacitentan, TadalafilOpsynvi
How Macitentan, Tadalafil interacts with SARMS Complete — through 2 ingredients. Tap an ingredient for the detail:
4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Macitentan, Tadalafil interaction((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs, Cytochrome P450 2c9 (cyp2c9) Substrates Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Macitentan, Tadalafil interactionMaravirocCelsentri, Selzentry
How Maraviroc interacts with SARMS Complete — through 2 ingredients. Tap an ingredient for the detail:
4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Maraviroc interaction((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Maraviroc interactionMephenytoinMesantoin
How Mephenytoin interacts with SARMS Complete — through 2 ingredients. Tap an ingredient for the detail:
((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideCytochrome P450 2c9 (cyp2c9) Substrates, Cytochrome P450 3a4 (cyp3a4) Inducers +1 Moderate
Interaction Summary
Theoretically, ostarine might increase levels of drugs metabolized by CYP2C9, although clinical research suggests this is not clinically relevant.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Mephenytoin interaction4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Mephenytoin interactionMercaptopurinePurixan
How Mercaptopurine interacts with SARMS Complete — through 2 ingredients. Tap an ingredient for the detail:
4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Mercaptopurine interaction((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Mercaptopurine interactionMestranol, NorethindroneNecon 1/50, Nelova 1/50M, Norethin 1/50, Norethin 1/50M, Norinyl 1 50 21 Day, Ortho Novum 1 Plus 50 +2 more
How Mestranol, Norethindrone interacts with SARMS Complete — through 2 ingredients. Tap an ingredient for the detail:
((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideCytochrome P450 3a4 (cyp3a4) Inhibitors, Hepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use of ostarine with CYP3A4 inhibitors could increase the effects and adverse effects of ostarine, although this is unlikely to be clinically significant.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Mestranol, Norethindrone interaction4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Mestranol, Norethindrone interactionMestranol, NorethynodrelEnovid-E
How Mestranol, Norethynodrel interacts with SARMS Complete — through 2 ingredients. Tap an ingredient for the detail:
((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Mestranol, Norethynodrel interaction4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Mestranol, Norethynodrel interactionMetformin, RosiglitazoneAvandamet
How Metformin, Rosiglitazone interacts with SARMS Complete — through 2 ingredients. Tap an ingredient for the detail:
((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideCytochrome P450 2c9 (cyp2c9) Substrates, Hepatotoxic Drugs Moderate
Interaction Summary
Theoretically, ostarine might increase levels of drugs metabolized by CYP2C9, although clinical research suggests this is not clinically relevant.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Metformin, Rosiglitazone interaction4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Metformin, Rosiglitazone interactionMethenamine MandelateMandelamine, Methimazole
How Methenamine Mandelate interacts with SARMS Complete — through 2 ingredients. Tap an ingredient for the detail:
4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Methenamine Mandelate interaction((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Methenamine Mandelate interactionMethimazoleTapazole
How Methimazole interacts with SARMS Complete — through 2 ingredients. Tap an ingredient for the detail:
4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Methimazole interaction((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Methimazole interactionMethotrexateOtrexup, Rasuvo, Reditrex, Rheumatrex
How Methotrexate interacts with SARMS Complete — through 2 ingredients. Tap an ingredient for the detail:
((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Methotrexate interaction4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Methotrexate interactionMethotrexate SodiumXatmep
How Methotrexate Sodium interacts with SARMS Complete — through 2 ingredients. Tap an ingredient for the detail:
((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Methotrexate Sodium interaction4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Methotrexate Sodium interactionMethyldopaAldomet, Methyldopa
How Methyldopa interacts with SARMS Complete — through 2 ingredients. Tap an ingredient for the detail:
4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Methyldopa interaction((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Methyldopa interactionMethyltestosteroneAndroid 10, Android 25, Metandren, Methitest, Oreton, Testred +1 more
How Methyltestosterone interacts with SARMS Complete — through 3 ingredients. Tap an ingredient for the detail:
(2s)-3-(4-acetamido-phenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethyl-phenyl)-propionamideAndrogens Moderate
Interaction Summary
Due to its androgenic properties, Andarine (S-4) may theoretically interact with other androgenic drugs, potentially increasing the risk of side effects associated with androgenic activity (source: https://pubmed.ncbi.nlm.nih.gov/12604714/).
Read the full (2s)-3-(4-acetamido-phenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethyl-phenyl)-propionamide + Methyltestosterone interaction4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Methyltestosterone interaction((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Methyltestosterone interactionMethyltestosterone BuccalAndroid 5, Oreton Buccal
How Methyltestosterone Buccal interacts with SARMS Complete — through 3 ingredients. Tap an ingredient for the detail:
((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Methyltestosterone Buccal interaction(2s)-3-(4-acetamido-phenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethyl-phenyl)-propionamideAndrogens Moderate
Interaction Summary
Due to its androgenic properties, Andarine (S-4) may theoretically interact with other androgenic drugs, potentially increasing the risk of side effects associated with androgenic activity (source: https://pubmed.ncbi.nlm.nih.gov/12604714/).
Read the full (2s)-3-(4-acetamido-phenoxy)-2-hydroxy-2-methyl-n-(4-nitro-3-trifluoromethyl-phenyl)-propionamide + Methyltestosterone Buccal interaction4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Methyltestosterone Buccal interactionMetronidazole, Tetracyline, Bismuth Subcitrate PotassiumPylera
How Metronidazole, Tetracyline, Bismuth Subcitrate Potassium interacts with SARMS Complete — through 2 ingredients. Tap an ingredient for the detail:
((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideCytochrome P450 3a4 (cyp3a4) Inhibitors, Hepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use of ostarine with CYP3A4 inhibitors could increase the effects and adverse effects of ostarine, although this is unlikely to be clinically significant.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Metronidazole, Tetracyline, Bismuth Subcitrate Potassium interaction4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Metronidazole, Tetracyline, Bismuth Subcitrate Potassium interactionMinocyclineAcnamino MR, Aknemin, Amzeeq, Arestin Miscrosperes, Dynacin, Minocin +6 more
How Minocycline interacts with SARMS Complete — through 2 ingredients. Tap an ingredient for the detail:
((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Minocycline interaction4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Minocycline interactionMinocycline HydrochlorideMinolira, Ximino
How Minocycline Hydrochloride interacts with SARMS Complete — through 2 ingredients. Tap an ingredient for the detail:
((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamideHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Read the full ((2s)-3-(4-cyanophenoxy)-n-[4-cyano-3-(trifluorometh-yl)phenyl]-2-hydroxy-2-methylpropanamide + Minocycline Hydrochloride interaction4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrileHepatotoxic Drugs Moderate
Interaction Summary
Theoretically, concomitant use might have additive hepatotoxic effects.
Read the full 4-((r)-2-((r)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoromethyl)benzonitrile + Minocycline Hydrochloride interactionEach ingredient & the kinds of drugs it affects
For each ingredient in SARMS Complete with known interactions, here are the types of medications they can affect. Open any type for the detail — or search your exact drug in the checker above.
((2S)-3-(4-Cyanophenoxy)-N-[4-Cyano-3-(Trifluorometh-yl)phenyl]-2-Hydroxy-2-Methylpropanamide
Cytochrome P450 3A4 (Cyp3A4) Inducers
Theoretically, concomitant use of ostarine with CYP3A4 inducers could decrease the clinical effects of ostarine.
Ostarine is partially metabolized by CYP3A4. Clinical research shows that taking rifampin, a potent inducer of CYP3A4, reduces the maximum plasma concentration of ostarine by 23% and the area under the curve by 43%.
Hepatotoxic Drugs
Theoretically, concomitant use with hepatotoxic drugs might increase the risk of adverse hepatotoxic effects.
Some clinical research shows that ostarine can increase alanine aminotransferase, a marker of liver damage, in some patients. Additionally, the U.S. Food and Drug Administration warns that supplements containing SARMs, such as ostarine, have been associated with reports of liver toxicity and there are at least two reports of drug-induced liver injury attributed to the use of ostarine.
Probenecid (Benemid)
Theoretically, concomitant use of ostarine with probenecid could increase the effects and adverse effects of ostarine.
Clinical research shows that probenecid increases ostarine levels and slows the clearance of ostarine, likely via inhibition of UDP-glucuronosyltransferase (UGT). Ostarine is partially metabolized by UGT.
Rifampin (Rifadin)
Theoretically, concomitant use of ostarine with rifampin could decrease the clinical effects of ostarine.
Clinical research shows that taking rifampin with ostarine reduces the maximum plasma concentration of ostarine by 23% and the area under the curve by 43%. Ostarine is partially metabolized by cytochrome P450 3A4 (CYP3A4), and rifampin is a potent CYP3A4 inducer.
Cytochrome P450 2C9 (Cyp2C9) Substrates
Theoretically, ostarine might increase levels of drugs metabolized by CYP2C9, although clinical research suggests this is not clinically relevant.
Although in vitro research suggests that ostarine inhibits CYP2C9, more robust clinical research shows that ostarine does not significantly affect CYP2C9.
Cytochrome P450 3A4 (Cyp3A4) Inhibitors
Theoretically, concomitant use of ostarine with CYP3A4 inhibitors could increase the effects and adverse effects of ostarine, although this is unlikely to be clinically significant.
Ostarine is partially metabolized by CYP3A4. However, clinical research shows that taking itraconazole, a potent inhibitor of CYP3A4, had minimal effects on the levels of ostarine in the body.
4-((R)-2-((R)-2,2,2-Trifluoro-1-Hydroxyethyl)Pyrrolidin-1-Yl)-2-TrifluoroMethyl)Benzonitrile
Hepatotoxic Drugs
Theoretically, concomitant use might have additive hepatotoxic effects.
In case reports, patients were diagnosed with liver injury thought to be related to the use of products containing ligandrol.
(2S)-3-(4-Acetamido-Phenoxy)-2-Hydroxy-2-Methyl-N-(4-Nitro-3-Trifluoromethyl-Phenyl)-Propionamide
Androgens
Due to its androgenic properties, Andarine (S-4) may theoretically interact with other androgenic drugs, potentially increasing the risk of side effects associated with androgenic activity (source: https://pubmed.ncbi.nlm.nih.gov/12604714/). These side effects can include masculinization, virilization, acne, hair loss, increased libido, aggression, mood changes, and liver toxicity.
Brand information
Manufacturer and brand details for SARMS Complete, from the product label.
AAS Applied Anabolic Science
See all AAS Applied Anabolic Science products- Name
- Applied Anabolic Science
- Street Address
- 4466 S. Staples
- City
- Corpus Christi
- State
- TX
- ZipCode
- 78411
SARMS Complete by AAS Applied Anabolic Science: Common Questions
Does SARMS Complete by AAS Applied Anabolic Science interact with any medications?
How can one product interact with so many drugs?
Where does this information come from?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Not sure if SARMS Complete is safe with your meds?
Our pharmacists answer your medication & supplement questions — free.
Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.
The Full Monographs Behind SARMS Complete’s Ingredients
Every ingredient we hold a full HelloPharmacist monograph for — uses, evidence, safety, and the complete interaction list.
Andarine
Interacts with 9 drugsAndarine (S-4) is a synthetic selective androgen receptor modulator (SARM) that is not approved by the FDA for human use and is banned in sports. It is not a legal dietary supplement ingredi...
Read the full Andarine monograph → Herb & supplement monographOstarine
Interacts with 611 drugsOstarine (also called MK-2866 or enobosarm) is an experimental, unapproved drug known as a SARM (selective androgen receptor modulator), not a true dietary supplement. It is not approved by...
Read the full Ostarine monograph → Herb & supplement monographLigandrol
Interacts with 370 drugsLigandrol (LGD-4033) is a synthetic selective androgen receptor modulator (SARM), not a natural herb or approved dietary supplement. It is not approved for human use, is banned in sports, an...
Read the full Ligandrol monograph →Sources & How We Checked
SARMS Complete's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.
- NIH Dietary Supplement Label Database (DSLD) — The official product label on file for this supplement.
- Natural Medicines (Therapeutic Research Center) — Evidence-graded clinical reference behind the ingredient interaction data.
Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.
The 20 references behind this product’s interaction data
Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.
Andarine 1 reference
- FDA. FDA Warns against using SARMs in body building products. October 2017. Available at: https://www.fda.gov/newsevents/newsroom/fdainbrief/ucm583021.htm.
Ostarine 10 references
- Warning Letter: Ironmag Labs 10/23/17. FDA Inspections, Compliance, Enforcement, and Criminal Investigations, October 23, 2017. https://www.fda.gov/iceci/enforcementactions/warningletters/2017/ucm582464.htm Accessed: November 1, 2017
- Warning Letter: Panther Sports Nutrition 10/23/17. FDA Inspections, Compliance, Enforcement, and Criminal Investigations, October 23, 2017. https://www.fda.gov/iceci/enforcementactions/warningletters/2017/ucm581630.htm. Accessed: November 1, 2017
- Warning Letter: Infantry Labs LLC 10/23/17. FDA Inspections, Compliance, Enforcement, and Criminal Investigations, October 23, 2017. https://www.fda.gov/iceci/enforcementactions/warningletters/2017/ucm582685.htm. Accessed: November 1, 2017
- Dobs AS, Boccia RV, Croot CC, et al. Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial. Lancet Oncol 2013;14(4):335-45. PubMed
- Dalton JT, Barnette KG, Bohl CE, et al. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II tri
- Coss CC, Jones A, Dalton JT. Pharmacokinetic drug interactions of the selective androgen receptor modulator GTx-024 (enobosarm) with itraconazole, rifampin, probenecid, celecoxib and rosuvastatin. Invest New Drugs 2016;34(4):458-67. PubMed
- FDA. FDA Warns against using SARMs in body building products. October 2017. Available at: https://www.fda.gov/newsevents/newsroom/fdainbrief/ucm583021.htm.
- Bedi H, Hammond C, Sanders D, Yang HM, Yoshida EM. Drug-induced liver injury from enobosarm (ostarine), a selective androgen receptor modulator. ACG Case Rep J 2021;8(1):e00518. PubMed
- Kintz P, Gheddar L, Paradis C, et al. Peroxisome Proliferator-Activated Receptor Delta Agonist (PPAR- d) and Selective Androgen Receptor Modulator (SARM) Abuse: Clinical, Analytical and Biological Data in a Case Involving a Poisonous Combination of GW1516
- Weinblatt D, Roy S. Drug-Induced Liver Injury Secondary to Enobosarm: A Selective Androgen Receptor Modulator. J Med Cases 2022;13(5):244-248. PubMed
Ligandrol 9 references
- Joseph JF, Parr MK. Synthetic androgens as designer supplements. Curr Neuropharmacol. 2015;13(1):89-100. PubMed
- Warning Letter: Ironmag Labs 10/23/17. FDA Inspections, Compliance, Enforcement, and Criminal Investigations, October 23, 2017. https://www.fda.gov/iceci/enforcementactions/warningletters/2017/ucm582464.htm Accessed: November 1, 2017
- Warning Letter: Panther Sports Nutrition 10/23/17. FDA Inspections, Compliance, Enforcement, and Criminal Investigations, October 23, 2017. https://www.fda.gov/iceci/enforcementactions/warningletters/2017/ucm581630.htm. Accessed: November 1, 2017
- Warning Letter: Infantry Labs LLC 10/23/17. FDA Inspections, Compliance, Enforcement, and Criminal Investigations, October 23, 2017. https://www.fda.gov/iceci/enforcementactions/warningletters/2017/ucm582685.htm. Accessed: November 1, 2017
- Barbara M, Dhingra S, Mindikoglu AL. Drug-induced liver injury associated with alpha bolic (RAD-140) and alpha elite (RAD-140 and LGD-4033). ACG Case Rep J 2020;7(6):e00409. PubMed
- Barbara M, Dhingra S, Mindikoglu AL. Ligandrol (LGD-4033)-Induced Liver Injury. ACG Case Rep J 2020;7(6):e00370. PubMed
- Koller T, Vrbova P, Meciarova I, et al. Liver injury associated with the use of selective androgen receptor modulators and post-cycle therapy: Two case reports and literature review. World J Clin Cases 2021;9(16):4062-4071. PubMed
- Flores JE, Chitturi S, Walker S. Drug-induced liver injury by selective androgenic receptor modulators. Hepatol Commun. 2020;4(3):450-452. PubMed
- Basaria S, Collins L, Dillon EL, et al. The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men. J Gerontol A Biol Sci Med Sci 2013;68(1):87-95. PubMed
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC